Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-26-248349
Filing Date
2026-05-29
Accepted
2026-05-29 16:17:09
Documents
17

Document Format Files

Seq Description Document Type Size
1 S-3 d155546ds3.htm S-3 209125
2 EX-5.1 d155546dex51.htm EX-5.1 11018
3 EX-10.2 d155546dex102.htm EX-10.2 127803
4 EX-23.1 d155546dex231.htm EX-23.1 1711
5 EX-FILING FEES d155546dexfilingfees.htm   iXBRL EX-FILING FEES 18254
6 GRAPHIC g155546g00a01.jpg GRAPHIC 50978
7 GRAPHIC g155546g36b90.jpg GRAPHIC 2899
8 GRAPHIC g155546g73j92.jpg GRAPHIC 6224
  Complete submission text file 0001193125-26-248349.txt   573636

Data Files

Seq Description Document Type Size
20 EXTRACTED XBRL INSTANCE DOCUMENT d155546dexfilingfees_htm.xml XML 5133
Mailing Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960
Business Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960 551-321-2234
Whitehawk Therapeutics, Inc. (Filer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-296353 | Film No.: 261044718
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)